Specify a stock or a cryptocurrency in the search bar to get a summary
Painreform Ltd
PRFXPainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations. The company was incorporated in 2007 and is based in Tel Aviv, Israel. Address: 65 Yigal Alon St., Tel Aviv, Israel, 6744316
Analytics
WallStreet Target Price
12 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures PRFX
Dividend Analytics PRFX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PRFX
Stock Valuation PRFX
Financials PRFX
Results | 2019 | Dynamics |